Press Releases

Stay up-to-date on the latest information from OmegaQuant.

For media inquiries, please contact Becky Wright, Marketing & Communications Director: becky@omegaquant.com

OmegaQuant Press Releases

OmegaQuant’s Dr. Bill Harris Named 2020 ASN Fellow

Read full release here.

OmegaQuant Partners with Standard Process to Offer the Omega-3 Index Test to Health Practitioners

Read full release here.

OmegaQuant Partners with Australia’s National Science Agency to Service APAC Region

Read full release here.

OmegaQuant Welcomes Omega-3 Blood Testing Statement from Major International Scientific Society

Read full release here.

Test Your Omega-3 Level for Free at FNCE 2019 & Learn About the Latest Omega-3 Studies

Read full release here.

OmegaQuant is the Official ‘Omega-3 Index Test Sponsor’ – Offering Free Testing at Vitafoods Asia 2019

Read full release here.

New Paper Creates Omega-3 Calculator For Researchers To Identify Proper EPA+DHA Doses in Studies

Read full release here.

OmegaQuant Makes Inc. 5000 List

Read full release here.

OmegaQuant Wins Award for the Prenatal DHA Initiative

Read full release here.

OmegaQuant’s Omega-3 Tests Now Registered in the EU

Read full release here.

Omega-3 Expert Supports New Research Showing that Omega-6 is Good for You

Read full release here.

New Research Shows People with PAD Could Have an Omega-3 Deficiency

Read full release here.

OmegaQuant Launches the First Prenatal DHA Blood Test for Pregnant Women

Read full release here.

More Fish Consumption and Omega-3 Supplementation Needed to Push the Omega-3 Index to 8%

Read full release here.

New Research Proposes Target DHA Level for Pregnant Women

Read full release here.

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.